Craneware plc AGM Statement (8493V)
08 November 2017 - 6:00PM
UK Regulatory
TIDMCRW
RNS Number : 8493V
Craneware plc
08 November 2017
Craneware plc
("Craneware", "the Group" or the "Company")
AGM Statement
8 November 2017 - Craneware plc (AIM: CRW.L), the leader in
Value Cycle solutions for the US healthcare market, will be holding
its Annual General Meeting today at 2pm. At the meeting, Keith
Neilson, CEO of the Company, will make the following statement:
"We have experienced a positive start to trading in the first
four months of the year, adding to the recent announcement of the
$6m contract win extending the scope of our solutions within an
existing customer. In June, we launched Trisus Claims Informatics,
the first product on our cloud-based Trisus platform, to which we
have seen a positive market response. In addition, we are seeing
very encouraging results for the early adopters of our Trisus Cost
Analytics Resource Efficiency product, which is currently under
development within Craneware Healthcare Intelligence.
"The sales activity and the early product successes demonstrate
how we are benefiting from our ongoing investments in our Value
Cycle product suite, ensuring we have the solutions that provide
insight into key areas of hospital operations, expanding our market
opportunity and increasing our strategic value within our
market.
"Our leadership in this area has further strengthened
Craneware's position as a trusted partner for US healthcare
organisations as they look to solve the challenges of the new value
based reimbursement models.
"This positive impact of the Value Cycle on current sales and
underlying pipelines combined with the high levels of revenue
visibility and significant cash reserves, means we are well
positioned to continue to execute on our growth strategy."
For further information, please contact:
Craneware plc Peel Hunt Alma
+44 (0)131 550 +44 (0)20 7418 +44 (0)208 004
3100 8900 4218
Keith Neilson, Dan Webster Caroline Forde
CEO
Craig Preston, Adrian Trimmings Hilary Buchanan
CFO
George Sellar Robyn Fisher
About Craneware
Craneware enables healthcare providers to improve margins and
enhance patient outcomes so they can continue to provide quality
outcomes for all.
Craneware is the leader in automated value cycle solutions that
help US healthcare provider organisations discover, convert and
optimise assets to achieve best clinical outcomes and financial
performance. Founded in 1999, Craneware has its headquarters in
Edinburgh, Scotland with offices in Atlanta, Boston and Phoenix
employing over 250 staff. Craneware's market-driven, SaaS solutions
normalise disparate data sets, bringing in up-to-date regulatory
and financial compliance data to deliver value at the points where
clinical and operational data transform into financial
transactions, creating actionable insights that enable informed
tactical and strategic decisions. To learn more, visit
craneware.com and thevaluecycle.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
AGMBCBDBGGGBGRR
(END) Dow Jones Newswires
November 08, 2017 02:00 ET (07:00 GMT)
Craneware (LSE:CRW)
Historical Stock Chart
From Apr 2024 to May 2024
Craneware (LSE:CRW)
Historical Stock Chart
From May 2023 to May 2024